Charles River Acquires Vigene Biosciences This acquisition will provide clients access to a comprehensive cell and gene therapy solution, including CDMO capabilities for viral vectors and plasmid DNA. learn more Research Models & Services Discovery Services Safety Assessment Laboratory Sciences Biologics Testing Solutions QC Microbial Solutions virtual conference World Congress: The Promises and Realities of Cell Therapy DATE October 26, 2021 10:00 AM-3:00 PM ET Learn More Featured Story On the Road to Developing a Variant-Proof COVID-19 Vaccine molecule type Cell and Gene Therapy Services and Products Insights Featured Story Expanded ddPCR Techniques Results in Higher Quality Data Learn More blog E40: Boosting the Signal for Vaccines Learn More Featured Story Asian PDX Model Data Now Available Learn More Vital Science Podcast S3, E01: A Synergistic Approach to Treating Huntington’s Disease Learn More View All
virtual conference World Congress: The Promises and Realities of Cell Therapy DATE October 26, 2021 10:00 AM-3:00 PM ET Learn More
